COVID-19

[faftorial]

At this point, if you’re able to get the J&J vaccine, do it without hesitation. The more people that are vaccinated, the better.

I'll be fine with that if that's what is available.

[meow]

Somebody convince me the J&J vaccine isn't second rate.

The single dose and minimal side effects are real appealing to a lot of people.

[faftorial]

Somebody convince me the J&J vaccine isn't second rate.

The single dose and minimal side effects are real appealing to a lot of people.

[tifosi77]

I will take whichever and as many vaccines as I can to speed up getting to the time to whenever I can cook for my friends again.

[NTP66]

Moderna said Wednesday it has shipped to the National Institutes of Health doses of a new Covid-19 vaccine designed to provide better protection against the highly contagious coronavirus variant spreading in South Africa.

The vaccine – which Moderna is calling mRNA-1273.351 – is ready to be tested in an early stage clinical trial to determine if it can be used as a booster shot against the South African strain, also known as B.1.351, the company said. Moderna has found its current two-dose regimen generates a weaker immune response against the strain from South Africa, though the company said antibodies in patients remain above levels that are expected to be protective against the virus.

“Moderna is committed to making as many updates to our vaccine as necessary until the pandemic is under control,” the company’s CEO, Stephane Bancel, said in a press release. “We hope to demonstrate that booster doses, if necessary, can be done at lower dose levels, which will allow us to provide many more doses to the global community in late 2021 and 2022 if necessary.”

The company said Wednesday that it plans to evaluate three approaches to increasing immunity. The first approach would use variant-specific booster shots, such as mRNA-1273.351, but at a lower dose than the original vaccine. The second one would combine the original vaccine with a variant-specific vaccine into a single shot at 50 micrograms or lower, Moderna said. The third would test a third shot of the original vaccine at a lower dosage.

[tifosi77]

The more people that are vaccinated, the less spread there will be, the less spread there is, the fewer chances for mutation, the less mutation, the more effective the vaccines are.

Please, just vaxx as many people as possible.

[NTP66]

Yes. I want to get back to some semblance of normalcy.

[faftorial]

Is anyone here NOT getting the vaccine when they are able to? @Nittany Ned @Ted

[King Colby]

The more people that are vaccinated, the less spread there will be, the less spread there is, the fewer chances for mutation, the less mutation, the more effective the vaccines are.

Please, just vaxx as many people as possible.

Nah. We're only doing health care workers, teachers, smokers, olds, and fats.

[dodint]

[Cagsjr724]

Just got an appointment for Saturday morning.

[Gaucho]

[meow]

We landed on the moon

[King Colby]

That's quite a stimulus package

[mamaemeritus]

Is anyone here NOT getting the vaccine when they are able to? @Nittany Ned @Ted

Potentially me. Concerned about autoimmune response.

[DigitalGypsy66]

As I am now eligible as a teacher, I called the state healthline to make an appointment (the website at the time had not been updated to allow new 1B people to sign up online). They couldn't get me an appointment at the big Darlington Raceway event on Friday, so I decided to wait until my employer set one up.

Then a bunch of people from work got appointments at the big event, so I went back to the website and snagged an appointment for tomorrow afternoon. I was hoping to take a couple of laps at the raceway, but it's only in the parking area, not on the track itself.

My wife gets her shot Saturday morning. Light at the end of the tunnel...

[faftorial]

As I am now eligible as a teacher, I called the state healthline to make an appointment (the website at the time had not been updated to allow new 1B people to sign up online). They couldn't get me an appointment at the big Darlington Raceway event on Friday, so I decided to wait until my employer set one up.

Then a bunch of people from work got appointments at the big event, so I went back to the website and snagged an appointment for tomorrow afternoon. I was hoping to take a couple of laps at the raceway, but it's only in the parking area, not on the track itself.

My wife gets her shot Saturday morning. Light at the end of the tunnel...

[RonnieFranchise]

For the Heinz Field clinic anyway it appears to be self certified. I mean I am obviously a fat guy but been asthmatic since I was a skinny high school student. All there is is a check box that says I reviewed qualifications and I qualify, so if it was just the asthma there are no instructions that say you better have a note from the doc.

Just sayin is all.

[count2infinity]

I would be getting myself ready to head to New Orleans next week for work had it not been for Covid... as much as I have really enjoyed a year off travel, this was one I was looking forward to. Sucks because this is the last time this conference (a big yearly one that I attend every year) would have been in New Orleans for the foreseeable future.

[mikey]

Barf...that sucks...

[MR25]

Moderna said Wednesday it has shipped to the National Institutes of Health doses of a new Covid-19 vaccine designed to provide better protection against the highly contagious coronavirus variant spreading in South Africa.

The vaccine – which Moderna is calling mRNA-1273.351 – is ready to be tested in an early stage clinical trial to determine if it can be used as a booster shot against the South African strain, also known as B.1.351, the company said. Moderna has found its current two-dose regimen generates a weaker immune response against the strain from South Africa, though the company said antibodies in patients remain above levels that are expected to be protective against the virus.

“Moderna is committed to making as many updates to our vaccine as necessary until the pandemic is under control,” the company’s CEO, Stephane Bancel, said in a press release. “We hope to demonstrate that booster doses, if necessary, can be done at lower dose levels, which will allow us to provide many more doses to the global community in late 2021 and 2022 if necessary.”

The company said Wednesday that it plans to evaluate three approaches to increasing immunity. The first approach would use variant-specific booster shots, such as mRNA-1273.351, but at a lower dose than the original vaccine. The second one would combine the original vaccine with a variant-specific vaccine into a single shot at 50 micrograms or lower, Moderna said. The third would test a third shot of the original vaccine at a lower dosage.

Now I guess the question is, is the immune response from NTP's post related to antibodies as opposed to T-Cell response?

[shoeshine boy]

I was hoping to take a couple of laps at the raceway, but it's only in the parking area, not on the track itself.

this would be another incentive for some of those backwoods rednecks that say they won't vaccinated.
"10 free laps with all shots!"

[NTP66]

Moderna said Wednesday it has shipped to the National Institutes of Health doses of a new Covid-19 vaccine designed to provide better protection against the highly contagious coronavirus variant spreading in South Africa.

The vaccine – which Moderna is calling mRNA-1273.351 – is ready to be tested in an early stage clinical trial to determine if it can be used as a booster shot against the South African strain, also known as B.1.351, the company said. Moderna has found its current two-dose regimen generates a weaker immune response against the strain from South Africa, though the company said antibodies in patients remain above levels that are expected to be protective against the virus.

“Moderna is committed to making as many updates to our vaccine as necessary until the pandemic is under control,” the company’s CEO, Stephane Bancel, said in a press release. “We hope to demonstrate that booster doses, if necessary, can be done at lower dose levels, which will allow us to provide many more doses to the global community in late 2021 and 2022 if necessary.”

The company said Wednesday that it plans to evaluate three approaches to increasing immunity. The first approach would use variant-specific booster shots, such as mRNA-1273.351, but at a lower dose than the original vaccine. The second one would combine the original vaccine with a variant-specific vaccine into a single shot at 50 micrograms or lower, Moderna said. The third would test a third shot of the original vaccine at a lower dosage.

Now I guess the question is, is the immune response from NTP's post related to antibodies as opposed to T-Cell response?

I would love to know the answer to this, as well. Some of these variants coming in and killing all progress would be such a huge blow. It's depressing.

[mikey]

Wow, I'm so, so, so surprised that the doom and gloom talk of variants and "nightmare" scenarios and all that is going to turn out to be mostly edge cases...

[NTP66]

Wow, I'm so, so, so surprised that the doom and gloom talk of variants and "nightmare" scenarios and all that is going to turn out to be mostly edge cases...

Don't you **** jinx it you NTP66